GLP and QA for Histology and Pathology of Drug Safety...

49
Quality and GLP for Histology and Pathology of Drug Safety Studies Roger Alison BVSc MRCVS DiplECVP Consultant Toxicological Pathologist www.rogeralison.com

Transcript of GLP and QA for Histology and Pathology of Drug Safety...

Quality and GLP

for Histology and Pathology of

Drug Safety Studies

Roger Alison BVSc MRCVS DiplECVP

Consultant Toxicological Pathologist

www.rogeralison.com

What is Quality Histology?

It depends upon the purpose

- Answer research questions

- Diagnosis

- Screening

- Support regulatory submissions

www.rogeralison.com

Quality Regulatory Histology

Fitness for the purpose

- Acceptability

- Reliability

- Consistency

- Reproducibility

- Retrievability

www.rogeralison.com

Quality Systems

- Good Laboratory Practice (GLP)

- Others:

- Good Clinical Practice (GCP)

- Good Manufacturing Practice (GMP)

- ISO 9000

www.rogeralison.com

GLP

Definition

- GLP is a quality system concerned with

the organisational process and the

conditions under which non-clinical

health and environmental safety studies

are planned, performed, monitored,

recorded, reported and archived.

www.rogeralison.com

Purpose of GLP

- Ensure consistent, reliable standards of

safety testing world-wide

- Promote the quality and integrity of test

data

- Improve human and environmental

safety

www.rogeralison.com

Origin of GLP

Introduced because of fraud or poor quality

work in US in 1970s:

- Dead animals “reappeared”

- Tumours “disappeared”

- Inadequate mixing of dose in diets

- Inadequate/insufficient documentation

- Replacement of animals

www.rogeralison.com

GLP is necessary...

Ethically: prevent fraud, public risk,

unnecessary use of animals

Economically: avoid waste of time and money

Scientifically: avoid acceptance of false

results

Regulatorily: ensure confidence in regulatory

decisions

www.rogeralison.com

GLP is required for...

All studies to assess the safety of:

- Drugs and medical devices

- Pesticides

- Chemicals

- Biologicals

www.rogeralison.com

Personnel

Sponsor

- Study Monitor

Test Facility/Test Site(s)

- Management

- Study Director/Principal Investigator(s)

- Study Personnel

- Lead Quality Assurance (facility)

- Test Site Quality Assurance Unit(s)

www.rogeralison.com

Sponsor

Commissions and submits GLP work

Responsible for:

- Ensuring laboratory is GLP compliant

- Test material information

- Approval of protocol

- Archiving – if contract laboratory or test

facility goes out of business

www.rogeralison.com

Management

Ensure GLP complied with:

- Designate a Study Director

- Ensure staff are trained and experienced

- Ensure adequate resources are available

- Approve SOPs

- Ensure QA programme exists (and

reports to management)

www.rogeralison.com

Study Director

The single point of study control

Takes responsibility for the overall conduct of

the study and its final report

www.rogeralison.com

Study Director ensures...

- GLP is followed

- Adequate trained personnel and suitable

equipment

- Personnel approve the protocol

- Protocol, amendments and SOPs are

available to study personnel

- Procedures specified in the protocol are

followed

www.rogeralison.com

Study Director ensures...

- Unforseen events are noted and assessed

- Raw data fully documented

- Approves and signs the report

- Archives study material promptly on

completion of the study

www.rogeralison.com

Principal Investigator

At sites separated from the SD, the PI

oversees critical phases of the study

- Drafts relevant protocol sections

- Ensures work is conducted to GLP and

in accordance with protocol and SOPs

- Prepares contributing report

- Ensures raw data is archived

www.rogeralison.com

Study Personnel

- Know Principles of GLP applicable to

their involvement in the study

- Ensure their training record is up to date

- Follow protocols, SOPs

- Report problems, mistakes, unexpected

events, and involved in corrective action

- Record data promptly, accurately,

completely

www.rogeralison.com

Quality Assurance

Independent of study conduct

- inspect study at intervals

- protocol

- in-life data, procedures

- report

- facilities

- Report to management and SD

www.rogeralison.com

Protocols and SOPs

Specify how a study is to be conducted:

- What is going to be done

- Who will do it

- When will it be done

- What data will be recorded

www.rogeralison.com

Protocols and SOPs

Protocols (study plans)

- Study specific instructions, often linking

SOPs and providing timings

SOPs:

- Standard: routine

- Operating: working

- Procedures: methods

www.rogeralison.com

Protocol

GLP requires:

- A written plan, before start of the study

- Verified for compliance by QA

- Approved by test facility management

(and usually by sponsor)

- Approved by dated signature of Study

Director

www.rogeralison.com

Protocol

Informs:

- Study staff, support staff

- Management

- Subcontractors, Principal Investigators

Confirms responsibilities (by signature):

- Study Director

- Management

- Principal Investigators

www.rogeralison.com

Protocol

Information included:

- When animals to be killed

- Tissues to be taken at necropsy

- Tissues to be processed

- Slides made: group, numbers, staining

- Slides examined (control, high dose?)

- Special techniques

- Staff responsible

www.rogeralison.com

Protocol Deviations

Protocol Amendments: (study plans)

- Planned changes to the original study

design

Protocol Deviations:

- Omissions or deviations (“errors”)

- Should be recorded separately

- Not as retrospective amendments

- Assessed for significance

www.rogeralison.com

SOPs

Histology SOPs:

- Tissue trimming

- Sectioning

- Staining, including special stains

- Equipment maintenance

- Records to be kept

- Slide shipping

- Chain of custody

www.rogeralison.com

SOPs

Guides for organ sampling and trimming in

rats and mice:

http://reni.item.fraunhofer.de/reni/trimming/

www.rogeralison.com

Adrenal Gland Trimming

www.rogeralison.com

- Through cortex

and medulla

- 1 per side

- Longitudinal

Seminal VesicleTrimming

www.rogeralison.com

- Mid section

- 1 per side

- TS, with

coagulating gland

SOPs

Benefits:

- Consistency (between staff, over time)

- Training

- Reconstruction of methods used in past

- Avoids repetitive documentation of

procedures

- Problems only have to be solved once

www.rogeralison.com

Data and Documentation

When the study is completed, the data,

documentation and samples must

completely support what was done

It must be possible for a third party to

reconstruct the study from what remains

www.rogeralison.com

Data and Documentation

Identifies:

- Who did it?

- When was it done?

- What was done?

- What were the results?

- Documents that SOPs and protocol were

followed

www.rogeralison.com

Data and Documentation

Raw Data:

- Original records (or verified copies) of

original observations and activities in the

study

- Recorded directly, promptly, accurately,

legibly and identified by who did it.

www.rogeralison.com

Data and Documentation

Raw Data:

- Original records (or verified copies) of

original observations and activities in the

study

- Recorded directly, promptly, accurately,

legibly and identified by who did it.

www.rogeralison.com

Histology Documentation

- Tissues taken

- Tissues trimmed

- Tissues in block

- Tissues on slide

- Staining procedures

- QC check done

www.rogeralison.com

Histology Quality

Pathologist’s niggles:

- Same blocking pattern every time, e.g.

ovaries/uterine horns/cervix/vagina

- No unnecessary extra sections

- No mixing slides of different thickness

- Same stain colour for control and treated

www.rogeralison.com

Histology Materials

Specimens (wet tissue, blocks, slides)

- Uniquely identified

- Retained

- Retrievable for future queries

www.rogeralison.com

Histology Quality Control

- Check that activities carried out properly

- Check all tissues taken at necropsy

- Check slide identification, sectioning,

staining

- Check tissue on slide

- Check data complete, signed

- Second person does it! Not QA!

www.rogeralison.com

Pathology Raw Data

- Record of the pathologist’s findings for

individual animals (when pathology data

finalised)

- Pathologist’s text interpreting the

findings

- (Possibly) computer file containing

study data

www.rogeralison.com

Pathology Quality Control

Peer Review:

- Review by a second pathologist of draft

report, 10% of animals, all neoplasms,

all target organs.

- Discussion of Peer Review findings

using double header microscope

- Final Report with consensus opinion

between pathologists

www.rogeralison.com

Pathology Quality Control

Peer Review:

- Typically takes two weeks for a

carcinogenicity study

- Data retained: records of animals and

organs examined, consensus achieved

- Not about “correcting” minor variations

between pathologists

- Best result as a collaborative exercise

www.rogeralison.com

Pathology Quality Control

Pathology Working Group (PWG):

- After report finalised, often mouse and

rat studies together

- Study pathologist, reviewing

pathologist, PWG leader, six “Experts”

- Characterise important or controversial

findings and assess their significance to

humans

www.rogeralison.com

Study Report

- Complete and accurate reflection of

protocol and raw data

- One study, one report

- Reviewed and approved by QA

- Signed by responsible people

- Date of report and finalisation is date

signed by study director

www.rogeralison.com

Archive

- All data and specimens retained after

study completion

- Secure, limited access

- Protected against deterioration

- Easily retrievable

- Regulations define period of retention,

but usually held for useful duration of

the compound

www.rogeralison.com

Computers

- Same principles of GLP apply

- Suitable for purpose

- Raw data defined

- Formal validation process of hardware

and software before operational use

- Maintenance, backup, disaster plan,

obsolescence and migration to new

system need to be defined

www.rogeralison.com

Multi-site Studies

Multi-site study

- Where phases are conducted on more

than one site

- Phase: a defined set of activities

- Test Facility: location of Study Director

- Test Sites: locations of other phases

- Principal Investigators: carry out duties

of study director at test sites

www.rogeralison.com

Multi-site Studies

Protocol

- Identify test sites, PI, and phases

- How test site data will be included in

report

SOPs

- Selection and monitoring of test site

- QA procedures

- Chain of custody for data and specimens

www.rogeralison.com

Multi-site Studies

Report

- One report for study

- Include PI contributions

- Include evidence of QA involvement

- Define archive location

- Indicate degree of GLP compliance

- Compliance statement for whole study

signed by Study Director

www.rogeralison.com

Multi-site Studies

Practical issues:

- Communication (Languages!)

- Defining responsibilities

- Assessment of test sites

- Monitoring and reporting of findings

- Chain of custody for samples and

specimens

www.rogeralison.com

Summary

GLP is little more than good scientific

practice, allowing:

- Repeatability

- Reconstruction

- Peer Review

It requires application of the same principles

as any good research:

- Discipline and Care

www.rogeralison.com